JNK (c-Jun N-terminal kinase), a kinase subfamily belonging to the MAPK, is activated in response to various stress stimuli and possesses a wide variety of regulatory functions.Three isoforms of the serine/threonine protein kinase JNK family (JNK1, JNK2, and JNK3) exist. JNKs play a role in the development and progression of many pathologies, including cancer, inflammatory diseases, cardiovascular and metabolic disorders, and neurodegenerative diseases.
JNKs are triggered by a phosphorylation cascade that typically involves two different upstream kinases, the so-called MAP kinase kinase kinases (MAP3K, MKKK) and the MAP kinase kinases (MAP2K; MKK). This process is similar to that used to activate the other MAP kinases. JNKs are triggered by MKK4 and MKK7 at the MAP2K level; the former is a shared activator of the JNK and p38 MAP kinase signaling pathways. The JNK cascade is a component of a complicated signaling network since it crosses numerous other routes at different places.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V138282 | JNK-IN-23 | 1007786-48-2 | JNK-IN-23 is a JNK inhibitor. |
|
V114252 | JNK-IN-25 | 1644498-54-3 | JNK-IN-25 is a highly potent and selective JNK1/2/3 inhibitor with IC50 values of 1.54 nM (JNK1), 1.99 nM (JNK2), and 0.75 nM (JNK3), respectively. |
|
V138284 | JNK-IN-26 | 2727965-47-9 | JNK-IN-26 is a JNK inhibitor. |
|
V12253 | JNK-IN-7 | 1408064-71-0 | JNK-IN-7 is a potent JNK inhibitor, inhibiting JNK1, JNK2 and JNK3 with IC50 of 1.5, 2 and 0.7 nM respectively. |
|
V138271 | JNK1 degrader-1 | JNK1 degrader-1 is a JNK1 HyT degrader. | |
|
V138272 | JNK1 ligand-1 | 325702-67-8 | JNK1 ligand-1 is a JNK1 ligand that can be used to synthesize PROTACs, such as PROTAC JNK1 degrader-1. |
|
V138273 | JNK1 ligand-1-NH-Ph-COOH | 3047792-63-9 | JNK1 ligand-1-NH-Ph-COOH is a selective JNK1 inhibitor. |
|
V116590 | JNK2 Recombinant Human Active Protein Kinase | JNK2 is a neuron-specific subtype of JNK. | |
|
V78318 | JNK2-IN-1 | 2998941-15-2 | JNK2-IN-1 (Compound J27) is a JNK2 inhibitor (Kds: 79.2 Μm). |
|
V138275 | JNK2/3-IN-1 | JNK2/3-IN-1 is an irreversible covalent c-Jun N-terminal kinase 2/3 (JNK2/3) inhibitor with IC50 values of 830 nM and 1909 nM, respectively. | |
|
V74392 | JNK3 inhibitor-3 | 2873465-25-7 | JNK3 inhibitor-3 (compound 15g) is a selective, BBB (blood-brain barrier) penetrating, orally bioactive c-Jun N-terminal kinase 3 (JNK3) inhibitor. |
|
V80457 | JNK3 inhibitor-6 | JNK3 inhibitor-6 (Compound A53) is a selective JNK3 inhibitor (IC50=78 nM). | |
|
V80458 | JNK3 inhibitor-8 | JNK3 inhibitor-8 is a specific, orally bioactive JNK3 inhibitor that can cross the BBB (blood-brain barrier). | |
|
V116625 | JNK3 Recombinant Human Active Protein Kinase | JNK3 is a neuron-specific subtype of JNK. | |
|
V138279 | JNK3-IN-10 | 3085181-00-3 | JNK3-IN-10 is a JNK3 inhibitor that is impermeable to the blood-brain barrier (IC50 = 0.257 nM) and has a selectivity for JNK1 that is more than 400 times greater. |
|
V0473 | TCS JNK 5a | 312917-14-9 | TCS JNK 5a (alsoknown asJNK Inhibitor IX; TCS JNK-5a) is a novel, highly selective and potent JNK (c-Jun N-terminal Kinase) inhibitor with potential antineoplastic activity. |
|
V0472 | JNK-IN-8 | 1410880-22-6 | JNK-IN-8 (JNK Inhibitor XVI; JNK-IN8) is the first irreversible/covalent inhibitor of pan-JNK (c-Jun N-terminal Kinase) with potential antitumor activity. |
|
V28892 | JNK Inhibitor VIII (TCS JNK 6o) | 894804-07-0 | JNK Inhibitor VIII (TCS JNK 6o) isa selective and ATP-competitive inhibitor of c-Jun N-terminal kinases (JNK-1, -2, and -3) with Kis of 2 nM, 4 nM, 52 nM, respectively, and has IC50 of 45 nM and 160 nM for JNK-1 and -2, respectively. |
|
V9844 | KB-R7943 mesylate | 182004-65-5 | KB-R7943 mesylate, the mesylate salt of KB-R-7943, is a novel and potent reverse Na(+) /Ca(2+) exchanger (NCX(rev)) with neuroprotective action. |
|
V51552 | L-JNKI-1 | L-JNKI-1 is a cell-penetrable peptide inhibitor of JNK. |